The treatment boosts the brain's ability to produce energy efficiently and reduces damaging oxidative stress by turning on genes for mitochondrial function and increasing natural antioxidant defenses.
Claim Context
Intranasal hiPSC-NSC-EVs enhance mitochondrial gene expression and reduce oxidative stress in the aged mouse hippocampus, increasing antioxidant proteins (NRF2, SOD) and decreasing lipid peroxidation (MDA) and protein oxidation (protein carbonyls), thereby improving cellular energy metabolism.
“hiPSC-NSC-EVs therapy... elevated expression of antioxidant proteins and genes that maintain mitochondrial respiratory chain integrity... reduced concentrations of MDA and PCs...”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether intranasal hiPSC-NSC-EVs consistently upregulate mitochondrial genes and reduce oxidative stress markers across multiple aging models and species.
A systematic review and meta-analysis of all studies using intranasal hiPSC-NSC-EVs in aged rodents, pooling data on hippocampal mitochondrial gene expression (Ndufs6, Sdha, Cox4i2), MDA, protein carbonyls, NRF2, and SOD levels, with standardized assays and risk-of-bias assessment.
That intranasal hiPSC-NSC-EVs cause a dose-dependent increase in mitochondrial gene expression and decrease in oxidative stress markers in aged mice.
A double-blind RCT in 80 aged C57BL/6 mice (20 months) randomized to 0, 6×10⁹, 12×10⁹, or 24×10⁹ hiPSC-NSC-EVs doses, with primary endpoints: hippocampal mRNA levels of Ndufs6, Sdha, Cox4i2, and protein levels of MDA, protein carbonyls, NRF2, and SOD at 7 days post-treatment.
Whether the degree of mitochondrial gene upregulation predicts the extent of cognitive improvement over time in aged mice.
A longitudinal cohort study of 100 aged mice treated with intranasal hiPSC-NSC-EVs, measuring mitochondrial gene expression (Ndufs6, Sdha) and oxidative stress markers (MDA, SOD) at 1, 3, and 6 months, and correlating these with longitudinal cognitive performance on NORT and OLT.
Whether aged mice with the most severe cognitive decline have the lowest mitochondrial gene expression and highest oxidative stress markers compared to cognitively preserved mice.
A case-control study comparing 30 aged mice with severe cognitive impairment (NORT DI <0.2) to 30 with preserved cognition (NORT DI >0.5), measuring baseline hippocampal mitochondrial gene expression and oxidative stress markers prior to any intervention.
Whether there is a correlation between mitochondrial gene expression levels and oxidative stress markers in aged mice at a single time point.
A cross-sectional analysis of 60 aged mice measuring hippocampal mRNA levels of Ndufs6, Sdha, Cox4i2 and protein levels of MDA, protein carbonyls, NRF2, and SOD, and correlating these with each other and with cognitive scores from a single NORT session.